Suman Kumar Dhar, born on 6 March 1968 in the Indian state of West Bengal, graduated in chemistry from Burdwan University in 1989 and completed his master's degree in biochemistry in 1992 from Kalyani University before securing a PhD in molecular biology from Jawaharlal Nehru University in 1998. After working briefly as a research assistant at the department of microbiology of the University of Nebraska, he did his post-doctoral studies at Brigham and Women’s Hospital of Harvard Medical School which he completed in 2001. Returning to India the same year, he joined Jawaharlal Nehru University as an assistant professor at the Special Centre for Molecular Medicine of the university where he rose in ranks to become an associate professor in 2005 and a professor in 2011, finally reaching the position of the chairperson of SCMM in 2011. In between, he served as a visiting fellow at Harvard Medical School, Harvard School of Public Health and Bernhard Nocht Institute for Tropical Medicine ; he also served as a Humboldt Research Fellow at Bernhard Nocht Institute in 2008. Besides his academic duties at JNU, Dhar is involved in the establishment of Centre of Excellence in Parasitology, a Department of Biotechnology-funded project. He was also a member of the proctorial committee constituted by JNU to inquire about the 2016 JNU protests.
Career
Dhar's research history starts during his graduate studies when he worked on Entamoeba histolytica, the protozoan which causes amoebiasis, focusing on its ribosomal DNA circle. Later at Harvard Medical School, his post-doctoral studies were centered on mammalian DNA replication which assisted him to identify the ORC6 and its role in viral DNA replication. He also identified geminin, a replication inhibitor, as a blocking factor of viral DNA replication, a discovery which earned him a US patent. Later, he studied the human pathogens, Helicobacter pylori and Plasmodium falciparum and their DNA replication and cell cycle regulation. He also worked on anti-malarial drugs and proposed Acriflavine as an anti-malarial agent, which has also been patented by him. His work has identified PfGyrase for P. falciparum and HpDnaB helicase for H. pylori as targets and these researches are reported to be helpful in drug discovery efforts for Gastric ulcers, Gastric adenocarcinomas and Malaria. Dhar has documented his research by way of a number of articles and online repositories such as PubMed and Pubfacts have listed many of them. He has contributed chapters to three books which include Epigenetics: Development and Disease by Tapas Kumar Kundu. He is associated with many science journals such as Journal of Biological Chemistry, Molecular Microbiology, FEBS Journal and Medical Science Monitor as an ad-hoc reviewer and has delivered featured talks including his oration at the Gordon Research Conference on Host-Parasite interaction held in Rhode Island in 2012.
